Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Sep;240(9):1963-1971.
doi: 10.1007/s00213-023-06417-4. Epub 2023 Aug 1.

No benefit of antidepressants in inpatient treatment of depression. A longitudinal, quasi-experimental field study

Reinhard Maß  1 , Kerstin Backhaus  2 , Katharina Lohrer  2 , Michael Szelies  2 , Bodo K Unkelbach  2
Affiliations

No benefit of antidepressants in inpatient treatment of depression. A longitudinal, quasi-experimental field study

Reinhard Maß et al. Psychopharmacology (Berl). 2023 Sep.

Abstract

Rationale: Antidepressants (AD) are mostly considered indispensable for the treatment of major depression. The vast majority of depressive inpatients are treated with AD. However, there is a growing body of studies indicating that the effectiveness of AD is greatly overestimated due to methodological issues with the AD efficacy studies (e.g., publication bias, unintentional unblinding, confusion between withdrawal symptoms and relapse).

Objectives: The benefit of the additional use of AD in the inpatient treatment of depression with intensive cognitive-behavioral therapy (CBT) has been investigated in a naturalistic design.

Methods: Depressiveness was assessed using the Beck Depression Inventory (BDI-II) during a preliminary interview (T0), at admission (T1), at discharge (T2), and at a 6-month follow-up (T3). Two study phases were compared: During Phase A, AD were recommended in accordance with the German guideline. In Phase B, AD were no longer recommended, and they were only prescribed upon explicit request from patients. In phase A (N = 574), 60.3% of all patients were taking AD at discharge. In Phase B (N = 424), 27.9% of patients were on AD at discharge. Apart from the difference in AD usage, the two treatment conditions were similar, and the samples did not significantly differ in terms of age, sex, diagnoses, history of suicide attempts, comorbid anxiety disorders, and unemployment.

Results: In both study phases, BDI-II scores were strongly decreased at T2 and T3, respectively, compared with T1. The BDI-II scores of the two phases did not differ at any of the measurement time points. Depression changes were similar in both phases. In sequential multiple regression analyses with the total sample, AD were no significant predictors for the reduction of depression at either T2 or T3.

Conclusions: The inpatient CBT was effective in depression. The effectiveness of CBT is not improved by the additional use of AD. The current prescribing practices of AD should be questioned.

Keywords: Antidepressants; Depression; Inpatient treatment; Psychotherapy.

PubMed Disclaimer

Conflict of interest statement

None.

References

    1. Angermeyer MC, van der Auwera S, Carta MG, Schomerus G. Public attitudes towards psychiatry and psychiatric treatment at the beginning of the 21st century: A systematic review and meta-analysis of population surveys. World Psychiatry. 2017;16:50–61. doi: 10.1002/wps.20383. - DOI - PMC - PubMed
    1. Baethge C, Assall OP, Baldessarini RJ. Systematic review of blinding assessment in randomized controlled trials in schizophrenia and affective disorders 2000–2010. Psychother Psychosom. 2013;82:152–160. doi: 10.1159/000346144. - DOI - PubMed
    1. Beck AT, Steer RA, Brown GK. Manual for beck depression inventory-II. San Antonio: Psychological Corporation; 1996.
    1. Blom MBJ, Jonker K, Dusseldorp E, Spinhoven P, Hoencamp E, Haffmans J, van Dyck R. Combination treatment for acute depression is superior only when psychotherapie is added to medication. Psychother Psychosom. 2007;76:289–297. doi: 10.1159/000104705. - DOI - PubMed
    1. Buckman JEJ, Saunders R, Cohen ZD, Barnett P, Clarke K, Ambler G, DeRubeis RJ, Gilbody S, Hollon SD, Kendrick T, Watkins E, Wiles N, Kessler D, Richards D, Sharp D, Brabyn S, Littlewood E, Salisbury C, White IR, Glyn Lewis G, Pilling S. The contribution of depressive ‘disorder characteristics’ to determinations of prognosis for adults with depression: An individual patient data meta-analysis. Psychol Med. 2021;51:1068–1081. doi: 10.1017/S0033291721001367. - DOI - PMC - PubMed

Substances

LinkOut - more resources